Melissa H Tukey1, Renda Soylemez Wiener. 1. The Pulmonary Center, Boston University School of Medicine, 72 E. Concord Street, R-304, Boston, MA 02118, USA. mtukey@bu.edu
Abstract
BACKGROUND: Little is known about trends in the utilization or complication rates of transbronchial lung biopsy, particularly in community hospitals. METHODS: We used the Healthcare Cost and Utilization Project Florida State Inpatient and State Ambulatory Surgical Databases to assess trends in transbronchial lung biopsy utilization in adults from 2000 to 2009. We subsequently calculated population based estimates of complications associated with transbronchial lung biopsy (iatrogenic pneumothorax and procedure-related hemorrhage) and identified characteristics associated with complications. RESULTS: From 2000 to 2009, the age-adjusted rate of transbronchial biopsies per 100,000 adults in Florida decreased by 25% from 74 to 55 (p < 0.0001), despite stability in the overall utilization of bronchoscopy. Analysis of 82,059 procedures revealed that complications associated with transbronchial biopsy were uncommon and stable over the study period, with 0.97% (95% CI 0.94-1.01%) of procedures complicated by pneumothorax, 0.55% (95% CI 0.52-0.58%) by pneumothorax requiring chest tube placement, and 0.58% (95% CI 0.55-0.61%) by procedure-related hemorrhage. Patients with COPD (OR 1.51, 95% CI 1.31-1.75) and women (OR 1.32, 95% CI 1.15-1.52) were at increased risk for pneumothorax, while renal failure (OR 2.85, 95% CI 2.10-3.87), cirrhosis (OR 2.31, 95% CI 1.18-4.52), older age (OR 1.17, 95% CI 1.09-1.25) and female sex (OR 1.40, 95% CI 1.17-1.68) were associated with higher risk of procedure-related hemorrhage. CONCLUSIONS: Utilization of transbronchial lung biopsy is decreasing relative to the overall use of bronchoscopy. Nevertheless, it remains a safe procedure with low risk of complications.
BACKGROUND: Little is known about trends in the utilization or complication rates of transbronchial lung biopsy, particularly in community hospitals. METHODS: We used the Healthcare Cost and Utilization Project Florida State Inpatient and State Ambulatory Surgical Databases to assess trends in transbronchial lung biopsy utilization in adults from 2000 to 2009. We subsequently calculated population based estimates of complications associated with transbronchial lung biopsy (iatrogenic pneumothorax and procedure-related hemorrhage) and identified characteristics associated with complications. RESULTS: From 2000 to 2009, the age-adjusted rate of transbronchial biopsies per 100,000 adults in Florida decreased by 25% from 74 to 55 (p < 0.0001), despite stability in the overall utilization of bronchoscopy. Analysis of 82,059 procedures revealed that complications associated with transbronchial biopsy were uncommon and stable over the study period, with 0.97% (95% CI 0.94-1.01%) of procedures complicated by pneumothorax, 0.55% (95% CI 0.52-0.58%) by pneumothorax requiring chest tube placement, and 0.58% (95% CI 0.55-0.61%) by procedure-related hemorrhage. Patients with COPD (OR 1.51, 95% CI 1.31-1.75) and women (OR 1.32, 95% CI 1.15-1.52) were at increased risk for pneumothorax, while renal failure (OR 2.85, 95% CI 2.10-3.87), cirrhosis (OR 2.31, 95% CI 1.18-4.52), older age (OR 1.17, 95% CI 1.09-1.25) and female sex (OR 1.40, 95% CI 1.17-1.68) were associated with higher risk of procedure-related hemorrhage. CONCLUSIONS: Utilization of transbronchial lung biopsy is decreasing relative to the overall use of bronchoscopy. Nevertheless, it remains a safe procedure with low risk of complications.
Authors: E P McCarthy; L I Iezzoni; R B Davis; R H Palmer; M Cahalane; M B Hamel; K Mukamal; R S Phillips; D T Davies Journal: Med Care Date: 2000-08 Impact factor: 2.983
Authors: Banafsheh Sadeghi; Ruth Baron; Patricia Zrelak; Garth H Utter; Jeffrey J Geppert; Daniel J Tancredi; Patrick S Romano Journal: Am J Med Qual Date: 2010 May-Jun Impact factor: 1.852
Authors: P A Bulpa; A M Dive; L Mertens; M A Delos; J Jamart; P A Evrard; M R Gonzalez; E J Installé Journal: Eur Respir J Date: 2003-03 Impact factor: 16.671
Authors: Peter M Hopkins; Christina L Aboyoun; Prashant N Chhajed; Monique A Malouf; Marshall L Plit; Stephen P Rainer; Allan R Glanville Journal: J Heart Lung Transplant Date: 2002-10 Impact factor: 10.247
Authors: N Facciolongo; M Patelli; S Gasparini; L Lazzari Agli; M Salio; C Simonassi; B Del Prato; P Zanoni Journal: Monaldi Arch Chest Dis Date: 2009-03
Authors: Asha Bonney; Michael Christie; Anne Beaty; Sebastian Lunke; Graham Taylor; Louis Irving; Daniel Steinfort Journal: J Thorac Dis Date: 2016-09 Impact factor: 2.895
Authors: Ana B Pavel; Joshua D Campbell; Gang Liu; David Elashoff; Steven Dubinett; Kate Smith; Duncan Whitney; Marc E Lenburg; Avrum Spira Journal: Cancer Prev Res (Phila) Date: 2017-09-06
Authors: Renda Soylemez Wiener; Michael K Gould; Christopher G Slatore; Benjamin G Fincke; Lisa M Schwartz; Steven Woloshin Journal: JAMA Intern Med Date: 2014-06 Impact factor: 21.873
Authors: Gerard A Silvestri; Anil Vachani; Duncan Whitney; Michael Elashoff; Kate Porta Smith; J Scott Ferguson; Ed Parsons; Nandita Mitra; Jerome Brody; Marc E Lenburg; Avrum Spira Journal: N Engl J Med Date: 2015-05-17 Impact factor: 91.245
Authors: K de Heer; M G M Kok; N Fens; E J M Weersink; A H Zwinderman; M P C van der Schee; C E Visser; M H J van Oers; P J Sterk Journal: J Clin Microbiol Date: 2015-12-16 Impact factor: 5.948